50
Views
3
CrossRef citations to date
0
Altmetric
Original Research

Long-term follow-up of seven patients with ophthalmopathy not associated with thyroid autoimmunity: heterogeneity of autoimmune ophthalmopathy

, , &
Pages 1063-1071 | Published online: 12 Jul 2012

References

  • WiersingaWMBartalenaLEpidemiology and prevention of Graves’ ophthalmopathyThyroid20021285586012487767
  • BurchHBWartofskyLGraves’ ophthalmopathy: Current concepts regarding pathogenesis and managementEndocr Rev1993147477938119236
  • BartleyGBFatourechiVKadrmasEFClinical features of Graves’ ophthalmopathy in an incidence cohortAm J Ophthalmol19961212842908597271
  • GopinathBTaniJBaoNWallJREye muscle and collagen XIII antibodies and eye signs in patients with transient and chronic thyroiditisThyroid2007171717274740
  • TjiangHLahootiHMcCorquodaleTParmarKRWallJREye and eyelid abnormalities are common in patients with Hashimoto’s thyroiditisThyroid20102028729020146657
  • EcksteinAKPlichtMLaxHThyrotropin receptor autoantibodies are independent risk factors for Graves’ ophthalmopathy and help to predict severity and outcome of the diseaseJ Clin Endocrinol Metab2006913464347016835285
  • PaschkeRVassartGLudgateMCurrent evidence for and against the TSH receptor being the common antigen in Graves’ disease and thyroid associated ophthalmopathyClin Endocrinol (Oxf)1995425655697634495
  • WeetmanAPGraves’ diseaseN Engl J Med20003431236124811071676
  • BahnRSClinical review 157: Pathophysiology of Graves’ ophthalmopathy: The cycle of diseaseJ Clin Endocrinol Metab2003881939194612727937
  • WallJRThe TSH-receptor and thyroid-associated ophthalmopathy: A convenient hypothesis with too many exceptions to be trueInt J Endocrinol Metab200724951
  • BeardNALaverDRDulhuntyAFCalsequestrin and the calcium release channel of skeletal and cardiac muscleBiophys Mol Biol2004853369
  • HaggPRehnMHuhtalaPVaisanenTTamminenMPihlajaniemiTType XIII collagen is identified as a plasma membrane proteinJ Biol Chem199827315590155979624150
  • GopinathBMusselmanRBeardNTaniJAdamsCWallJRAntibodies targeting the calcium binding skeletal muscle protein calsequestrin are sensitive and specific markers of ocular myopathy in patients with Graves’ diseaseClin Exp Immunol2006145566216792674
  • GopinathBMusselmanRAdamsCTaniJBeardNWallJRStudy of serum antibodies against three eye muscle antigens and the connective tissue antigen collagen XIII in patients with Graves’ disease with and without ophthalmopathy: Correlation with clinical featuresThyroid20061696797417042681
  • De BellisASansoneDCoronellaCSerum antibodies to collagen XIII: A further good marker of active Graves’ ophthalmopathyClin Endocrinol (Oxf)200562242915638866
  • NuneryWRMartinRTHeinzGWGavinTJThe association of cigarette smoking with clinical subtypes of ophthalmic Graves’ diseaseOphthal Plast Reconstr Surg199397782
  • MouritsMPKoornneefLWiersingaWMPrummelMFBerghoutAvan der GaagRClinical criteria for the assessment of disease activity in Graves’ ophthalmopathy: A novel approachBr J Ophthalmol1989736396442765444
  • WernerSCClassification of the eye changes of Graves’ diseaseAm J Ophthalmol1969686466485394450
  • WallJRKiljanskiJNebesVStachuraIKennerdellJSShould Graves’ disease be considered a collagen disorder of the thyroid, skeletal muscle and connective tissue?Hor Metab Res199527528532
  • WallJRExtra thyroidal manifestations of Graves’ diseaseJ Clin Endocrinol Metab199680342734298530578
  • SalviMZhangZGHaegertDPatients with endocrine ophthalmopathy not associated with overt thyroid disease have multiple thyroid immunological abnormalitiesJ Clin Endocrinol Metab19907089942294141
  • Medeiros-NetoGZhangZGLimaNImmunologically mediated cytotoxicity against human eye muscle and thyroid cells in euthyroid and thyrotoxic Graves’ ophthalmopathyAutoimmunity199192933001954309
  • HansenCFraitureBRouhiROttoEFörsterGKahalyGHPLC glycosaminoglycan analysis in patients with Graves’ diseaseClin Sci (Lond)1997925115179176026
  • KahalyGStoverCOttoEBeyerJSchulerMGlycosaminoglycans in thyroid-associated ophthalmopathyAutoimmunity19921381881420810
  • KimWBChungHKParkYJThe prevalence and clinical significance of blocking thyrotropin receptor antibodies in untreated hyperthyroid Graves’ diseaseThyroid20001057958610958310
  • TaniJWallJRAnalysis: Can the development of thyroid-associated ophthalmopathy be explained by autoimmunity against eye muscle antigens?Canad Med Assoc200617239241
  • TaniJGopinathBNuygenBWallJRImmunological mechanisms for the eye muscle and orbital connective tissue reactions of thyroid-associated ophthalmopathyExpert Rev Clin Immunol2007329931120477674
  • PorterJDKhannaSKaminskiHJExtraocular muscle is defined by a fundamentally distinct gene expression profileProc Natl Acad Sci U S A200198120621206711572940
  • HuangDXuNSongYWangPYangHInflammatory cytokine profiles in the tears of thyroid-associated ophthalmopathyGraefes Arch Clin Exp Ophthalmol2012250461962522124787
  • KhalilzadehOAnvariMEsteghamatiAGenetic susceptibility to Graves’ ophthalmopathy: The role of polymorphisms in anti-inflammatory cytokine genesOphthalmic Genet20103121522021067483